Fondaparinux Sodium vs Nivolumab

## Fondaparinux Sodium vs Nivolumab: Overview

This comparison examines the pharmacological differences between **Fondaparinux Sodium** and **Nivolumab**.

## Mechanism of Action

**Nivolumab**: Fully human anti-PD-1 IgG4 monoclonal antibody restoring T-cell anti-tumor activity.

## Pharmacokinetics

**Half-life**: Fondaparinux Sodium — N/A; Nivolumab — 27 days.

## Chemical Properties

**Type**: Fondaparinux Sodium — Oligosaccharide; Nivolumab — Antibody.